Introducing the results related to the programs that AMED's supports R&D
Achievements
What's New
-
2020.11.25Development of chemically - modified microRNA143-3p targeting RAS networks -
-
2020.11.24Enhanced therapeutic effects of EGFR inhibitors by transdermal administration of tumor-suppressive miRNA-634 - For practical applications of microRNA ointment for squamous cell skin cancer -
-
2020.11.24Production of glial cells, effective for spinal cord injury, from clinical human iPS cells - Promising cell sources for clinical applications -
-
2020.11.24Ultra-stable artificial protein retaining its folding ability even with loosened hydrophobic packing
-
2020.11.21Mechanism of action of a molecule that suppresses intracellular stress response - Drug candidate molecule for suppressing structural changes of a translation initiation factor into an inhibitory form -
-
2020.11.20Suppression of malignant transformation through the activation of β2 adrenergic receptor signals - For the development of novel oral cancer treatments with few side effects -
-
2020.11.13Elucidation of the binding mechanism of a cyclic peptide to human serum albumin - Accelerate the discovery of cyclic peptide drugs -
-
2020.11.11Associations between blood metabolites and genomes - Association analysis between plasma metabolomes and gene polymorphisms for future medical care -
-
2020.11.11A new mitochondrial function that controls responses to viral infection - Regulation of antiviral responses by sensing intracellular energy status -
-
2020.11.11Elucidation of brain patterning - A mechanism of distinct formation of the cerebral cortex and the basal ganglia -